Karen I. Sweiss
Clinical Assistant Professor, Pharmacy Practice
Email:
Related Sites:
About Heading link
Teaching and Supervision Heading link
Colloquium Lecture Series (PSCI 425), 8/26/2024 – 12/6/2024
Colloquium Lecture Series (PSCI 425), 8/26/2024 – 12/6/2024
Pathobiology of Cancer (PATH 511), 1/8/2024 – 4/26/2024
PDAT 9: Hematology/Oncology (PHAR 509), 1/8/2024 – 4/26/2024
PDAT 9: Hematology/Oncology (PHAR 509), 1/8/2024 – 4/26/2024
PDAT 9: Hematology/Oncology (PHAR 509), 1/8/2024 – 4/26/2024
PDAT 9: Hematology/Oncology (PHAR 509), 1/8/2024 – 4/26/2024
PDAT 9: Hematology/Oncology (PHAR 509), 1/8/2024 – 4/26/2024
PDAT 9: Hematology/Oncology (PHAR 509), 1/8/2024 – 4/26/2024
Selected Grants
MC-FludT19-PK: An Open-label, Non-randomized, Prospective Trial to Evaluate the Effect of Renal Function Impairment and Race/Ethnicity on Treosulfan Pharmacokinetics in Patients With AML or MDS Underg, Medac GmbH., 2/9/2024 - 2/9/2029, Obligated Amount: $83791; Anticipated Amount: $83791
Heme-18: Minimal Residual Disease-Guided Post-Autologous Transplant Maintenance with Isatuximab and Lenalidomide in Multiple Myeloma Patients, Sanofi., 6/1/2023 - 11/30/2023, Obligated Amount: $2660818.02; No Anticipated Amount Set
"MC-FludT19-PK: An Open-label, Non-randomized, Prospective Trial to Evaluate the Effect of Renal Function Impairment and Race/Ethnicity on Treosulfan Pharmacokinetics in Patients With AML or MDS Undergoing Allogeneic Hematopoietic Stem Cell Transplantation ", Medexus., 6/1/2023 - Present, No Obligated Amount Set; No Anticipated Amount Set
Expand Trial, Allogene., 5/1/2023 - Present, No Obligated Amount Set; No Anticipated Amount Set
Monumental-3, Janssen Biotech., 4/1/2023 - Present, No Obligated Amount Set; No Anticipated Amount Set
AB-205-301: A Phase 3 Double-Blind, Randomized, Placebo Controlled Study to Evaluate the Efficacy and Safety of AB-205 plus Standard of Care versus Placebo plus Standard of Care in, AB-205-301., 3/3/2023 - Present, No Obligated Amount Set; No Anticipated Amount Set
BMS CA057-001: A Phase 3, Two-Stage, Randomized, Multicenter, Open-Label Study Comparing CC-92480, Bortezomib and Dexamethasone (480Vd) Versus Pomalidomide, Bortezomib and Dexamethasone (PVd) in Subjects With Relapsed or Refractory Multiple Myeloma (RRMM), BMS CA057-001., 3/1/2023 - Present, No Obligated Amount Set; No Anticipated Amount Set
BGB-11417-105: A Phase 1b/2 Dose-Escalation and Cohort-Expansion Study to Determine the Safety and Efficacy of BGB 11417 as Monotherapy, in Combination With Dexamethasone and, Beigene., 2/1/2023 - Present, No Obligated Amount Set; No Anticipated Amount Set
CTA: HEME-18 - Post-Autologous Transplant Maintenance with Isatuximab and Lenalidomide in Minimal Residual Disease Positive Multiple Myeloma, Genzyme Corp., 8/23/2022 - 10/31/2026, Obligated Amount: $2660818.02; Anticipated Amount: $2660818.02
Selected Publications
Nabulsi, Nadia A, Sharp, Lisa K, Sweiss, Karen I, Patel, Pritesh R, Calip, Gregory S, Lee, Todd A. (2024). Patterns of prescription opioid use and opioid-related harms among adult patients with hematologic malignancies. Journal of Oncology Pharmacy Practice, 30, (8), 1317-1329. doi:10.1177/10781552231210788.
Mohyuddin, Ghulam Rehman, Guadamuz, Jenny S, Ascha, Mustafa S, Chiu, Brian C-H, Patel, Pritesh R, Sweiss, Karen, Rohrer, Rebecca, Sborov, Douglas, Calip, Gregory S. (2024). Comparison of patients with myeloma receiving zoledronic acid vs denosumab: a nationwide retrospective cohort study. Blood Advances, 8, (21), 5539-5541. doi:10.1182/bloodadvances.2024013600.
Cottini, Francesca, Avila Rodriguez, Ana Maria, Sweiss, Karen, Uzoka, Chukwuemeka, Chen, Zhengjia, Ma, Weiwei, Umyarova, Elvira, Satoskar, Anjali, Rodriguez, Pierre, Sanchez, Matias. (2024). Real-World Outcomes of Monoclonal Gammopathy of Renal Significance (MGRS) in the Era of Novel Therapies. Blood, 144, (Supplement 1), 3298-3298. doi:10.1182/blood-2024-198929.
Wahab, Ahsan, Sweiss, Karen, Birch, Noah, Sanchez, Matias. (2024). Has ABO Mismatch Rate Decreased in AML and ALL Transplant Recipients over the Years, a Trend Analysis Using CIBMTR Data. Blood, 144, (Supplement 1), 2169-2169. doi:10.1182/blood-2024-209226.
Mohyuddin, Ghulam Rehman, Godara, Amandeep, McClune, Brian, Fortuna, Gliceida Galarza, Sweiss, Karen, Sanchez, Matias, Mian, Hira, Sborov, Douglas W. (2024). ULTRA FRAIL-MM Clinical Trial: Go-Slow Approach Incorporating Isatuximab, Lenalidomide and Dexamethasone for Ultra-Frail Newly Diagnosed Myeloma. Blood, 144, (Supplement 1), 6916-6916. doi:10.1182/blood-2024-208861.
Wahab, Ahsan, Sweiss, Karen, Sanchez, Matias. (2024). Association of Rh Mismatch with Primary Graft Failure and Overall Survival in Allogeneic Hematopoietic Stem Cell Recipients with Acute Leukemia, a CIBMTR Analysis. Blood, 144, (Supplement 1), 3568-3568. doi:10.1182/blood-2024-209278.
Sweiss, Karen, Hydren, Jay R, Hurtado Martinez, Jorge Arturo, Barnes, Mason S, Patel, Pritesh, Sborov, Douglas W, Ahlstrom, Jennifer M, Sharp, Lisa, Hofmeister, Craig C. (2024). National Healthtree Survey on Pain and Opioid Use Patterns and Perceptions Among Patients with Multiple Myeloma. Blood, 144, (Supplement 1), 283-283. doi:10.1182/blood-2024-210314.
Sweiss, Karen, Hydren, Jay R, Hurtado Martinez, Jorge Arturo, Barnes, Mason S, Patel, Pritesh, Sborov, Douglas W, Ahlstrom, Jennifer M, Sharp, Lisa, Hofmeister, Craig C. (2024). First Ever National Survey on Patient-Reported Efficacy and Safety of Cannabis in Patients with Multiple Myeloma. Blood, 144, (Supplement 1), 5144-5144. doi:10.1182/blood-2024-210437.
Proskuriakova, Ekaterina, Zucchetti, Elisa, Sweiss, Karen, Mahmud, Nadim, Koshy, Matthew, Rondelli, Damiano, Saraf, Santosh L. (2024). Haploidentical Peripheral Blood Stem Cell Transplantation in 20 Adult Patients with Sickle Cell Disease. Blood, 144, (Supplement 1), 2101-2101. doi:10.1182/blood-2024-198407.
Notable Honors
2020, 2020 Best Oral Abstract Award, BMT Pharmacist Conference at the 2020 Transplantation and Cellular Therapy (TCT) Conference
Selected Presentations
Sweiss, Karen. (2024 April 06). Updates and Challenges with BsAbs and CAR-T in Myeloma. Central Illinois Hematology Oncology Conference. Peoria, IL.
Sanchez, matias, Sweiss, Karen. (2024 January 31). Positioning the CART before the Horse: Sequencing of BsAbs and CAR-T. Multiple Myeloma Chicago Rounds.